Literature DB >> 7589835

Hyperglycemia activates glucose transport in rat skeletal muscle via a Ca(2+)-dependent mechanism.

L A Nolte1, J Rincón, E O Wahlström, B W Craig, J R Zierath, H Wallberg-Henriksson.   

Abstract

We investigated the acute effect of hyperglycemia on 3-O-methylglucose transport in isolated rat epitrochlearis muscles. High levels of glucose (20 mmol/l) induced an approximately twofold increase in the rate of glucose transport when compared with muscles exposed to a low level of glucose (8 mmol/l) (P < 0.001). The hyperglycemic effect was additive to the effects of both insulin and exercise on the glucose transport rates. Dantrolene (25 mumol/l), a potent inhibitor of Ca2+ release from the sarcoplasmic reticulum, blocked the ability of hyperglycemia to increase glucose transport by 73% (P < 0.01). Although dantrolene had no effect on the non-insulin-stimulated or the insulin-stimulated glucose transport rates during normoglycemic conditions, the effect of exercise was completely blocked in the presence of dantrolene (P < 0.01). Inhibition of phosphatidylinositol (PI) 3-kinase by wortmannin (500 nmol/l) had no effect on the activation of glucose transport by hyperglycemia, whereas the insulin-stimulated glucose transport was completely abolished (P < 0.001). These findings suggest that hyperglycemia activates glucose transport by a Ca(2+)-dependent activation of glucose transport does not involve the activation of PI 3-kinase and is separate from the mass-action effect of glucose on glucose transport.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589835     DOI: 10.2337/diab.44.11.1345

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  Chronic insulin effects on insulin signalling and GLUT4 endocytosis are reversed by metformin.

Authors:  P R Pryor; S C Liu; A E Clark; J Yang; G D Holman; D Tosh
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

Review 2.  Alterations of glucose metabolism in type 2 diabetes mellitus. An overview.

Authors:  Riccardo C Bonadonna
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

3.  Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production.

Authors:  Sylvia Kehlenbrink; Julia Tonelli; Sudha Koppaka; Visvanathan Chandramouli; Meredith Hawkins; Preeti Kishore
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-05-05       Impact factor: 4.310

4.  Non-steroidal anti-inflammatory drugs attenuate the vascular responses in aging metabolic syndrome rats.

Authors:  María Esther Rubio-Ruiz; Israel Pérez-Torres; Eulises Diaz-Diaz; Natalia Pavón; Verónica Guarner-Lans
Journal:  Acta Pharmacol Sin       Date:  2014-09-29       Impact factor: 6.150

5.  Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM.

Authors:  J R Zierath; L He; A Gumà; E Odegoard Wahlström; A Klip; H Wallberg-Henriksson
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

Review 6.  The forgotten role of glucose effectiveness in the regulation of glucose tolerance.

Authors:  Simmi Dube; Isabel Errazuriz-Cruzat; Ananda Basu; Rita Basu
Journal:  Curr Diab Rep       Date:  2015-06       Impact factor: 4.810

7.  Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia.

Authors:  X Fan; C P C Borba; P Copeland; D Hayden; O Freudenreich; D C Goff; D C Henderson
Journal:  Acta Psychiatr Scand       Date:  2012-09-04       Impact factor: 6.392

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.